Amber Implants is heading to the 40th North American Spine Society Annual Meeting, Nov 14–16 in Denver. Our CEO, Vincent Gardès, and CTO, Mo Ahmadi, will showcase the VCFix® Spinal System, our innovative solution for vertebral compression fractures. As we enter the U.S. market, this is a pivotal moment for us to connect with industry representatives and clinical professionals at the premier global event in the spine industry.
About Amber Implants
Amber Implants is now a commercial stage company, preparing for its US launch in 2026. Supported by strong worldwide patent protection and a growing product pipeline, the Company is on track to capture a significant share of the global €2 billion+ vertebral compression fracture market by 2029. FDA clearance of the VCFix® Spinal System not only accelerates adoption and revenue growth but also serves as a gateway for entry into additional global markets where FDA approval is recognized.
